Related Experiment Videos

Myofibrillar myopathy: no evidence of apoptosis by TUNEL

A A Amato1, C E Jackson, S Lampkin

  • 1Department of Medicine/Neurology, University of Texas Health Science Center at San Antonio, 78284-7883, USA.

Neurology
|March 17, 1999
PubMed

Insights

The exact cause of myofibrillar myopathy (MFM) remains unknown. This study found no evidence of apoptosis in MFM muscle biopsies, suggesting other mechanisms may be involved.

Area of Science:

  • Neurology
  • Cell Biology
  • Muscle Diseases

Background:

  • Myofibrillar myopathy (MFM) pathogenesis is poorly understood.
  • Muscle biopsies show cell cycle protein and ectopic cytoplasmic protein expression, hinting at apoptosis.
  • Apoptosis was investigated as a potential mechanism in MFM.

Purpose of the Study:

  • To investigate the presence of apoptosis in muscle biopsy specimens from patients with myofibrillar myopathy.
  • To explore potential cellular mechanisms contributing to MFM.

Main Methods:

  • Analysis of six muscle biopsy specimens from MFM patients.
  • Utilized the TUNEL (terminal deoxynucleotidyl transferase dUTP nick end labeling) assay to detect apoptotic myonuclei.

Main Results:

  • No evidence of apoptotic myonuclei was found in any of the examined MFM muscle biopsies.
  • The TUNEL assay did not confirm apoptosis as a primary feature in these MFM cases.

Conclusions:

  • Apoptosis does not appear to be a significant factor in the pathogenesis of the studied MFM cases.
  • Further research is required to elucidate MFM pathogenesis, potentially exploring roles for other cellular events like mitotic catastrophe.

Related Concept Videos